{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:26:03Z","timestamp":1788852363993,"version":"build-2803163510"},"reference-count":24,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2024.2767","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T11:10:33Z","timestamp":1722251433000},"source":"Crossref","is-referenced-by-count":5,"title":["Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of <i>PDGFRA<\/i>, <i>VEGFR2<\/i> and <i>KIT<\/i>: A case report"],"prefix":"10.3892","volume":"21","author":[{"given":"Haruki","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Nakai","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Imura","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565\u20110871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565\u20110871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiyo","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Wakamatsu","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Tamiya","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetatsu","family":"Outani","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565\u20110871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yagi","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kakunaga","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541\u20118567, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"key20240903130509_b1-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"key20240903130509_b2-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"key20240903130509_b3-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cncr.25538","article-title":"Trends in survival for patients with metastatic soft-tissue sarcoma","volume":"117","author":"Italiano","year":"2011","journal-title":"Cancer"},{"key":"key20240903130509_b4-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/ans.15348","article-title":"Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: A 20-year experience of 266 cases","volume":"89","author":"Vodanovich","year":"2019","journal-title":"ANZ J Surg"},{"key":"key20240903130509_b5-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.022","article-title":"Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes","volume":"79","author":"Winchester","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key20240903130509_b6-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2010.02.012","article-title":"Pazopanib: Clinical development of a potent anti-angiogenic drug","volume":"77","author":"Schutz","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20240903130509_b7-MCO-21-4-02767","first-page":"145","article-title":"Pazopanib and soft-tissue sarcomas. Too toxic","volume":"22","year":"2013","journal-title":"Prescrire Int"},{"key":"key20240903130509_b8-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/cncr.29961","article-title":"The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese musculoskeletal oncology group (JMOG) study","volume":"122","author":"Nakamura","year":"2016","journal-title":"Cancer"},{"key":"key20240903130509_b9-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2013.49.4799","article-title":"Precision oncology: An overview","volume":"31","author":"Garraway","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20240903130509_b10-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrc3612","article-title":"Tyrosine kinase gene rearrangements in epithelial malignancies","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20240903130509_b11-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2771","article-title":"A census of amplified and overexpressed human cancer genes","volume":"10","author":"Santarius","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20240903130509_b12-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4103\/1947-2714.163641","article-title":"Amplification of cellular oncogenes in solid tumors","volume":"7","author":"Bagci","year":"2015","journal-title":"N Am J Med Sci"},{"key":"key20240903130509_b13-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1634\/theoncologist.2018-0528","article-title":"The pan-cancer landscape of coamplification of the tyrosine kinases KIT, KDR, and PDGFRA","volume":"25","author":"Disel","year":"2020","journal-title":"Oncologist"},{"key":"key20240903130509_b14-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/annonc\/mdw287","article-title":"A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma","volume":"27","author":"Ho","year":"2016","journal-title":"Ann Oncol"},{"key":"key20240903130509_b15-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ng.619","article-title":"Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy","volume":"42","author":"Barretina","year":"2010","journal-title":"Nat Genet"},{"key":"key20240903130509_b16-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"key20240903130509_b17-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1158\/1535-7163.MCT-07-0193","article-title":"Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity","volume":"6","author":"Kumar","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20240903130509_b18-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.biopha.2017.10.058","article-title":"The role of pazopanib on tumour angiogenesis and in the management of cancers: A review","volume":"96","author":"Chellappan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"key20240903130509_b19-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1634\/theoncologist.2009-0274","article-title":"(Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor","volume":"15","author":"Hamberg","year":"2010","journal-title":"Oncologist"},{"key":"key20240903130509_b20-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1080\/0284186X.2017.1332779","article-title":"Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: Results of the SPIRE study","volume":"56","author":"Gelderblom","year":"2017","journal-title":"Acta Oncol"},{"key":"key20240903130509_b21-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/annonc\/mdt586","article-title":"Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: Subanalysis of two European Organisation for research and treatment of cancer (EORTC) clinical trials 62043 and 62072","volume":"25","author":"Kasper","year":"2014","journal-title":"Ann Oncol"},{"key":"key20240903130509_b22-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejca.2022.05.025","article-title":"Gene expression-based prediction of pazopanib efficacy in sarcoma","volume":"172","author":"Heilig","year":"2022","journal-title":"Eur J Cancer"},{"key":"key20240903130509_b23-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1097\/CORR.0000000000001322","article-title":"Assessment of predictive biomarkers of the response to pazopanib based on an integrative analysis of high-grade soft-tissue sarcomas: Analysis of a tumor sample from a responder and patients with other soft-tissue sarcomas","volume":"478","author":"Suehara","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"key20240903130509_b24-MCO-21-4-02767","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/annonc\/mdv598","article-title":"TP53 mutational status is predictive of pazopanib response in advanced sarcomas","volume":"27","author":"Koehler","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T10:06:04Z","timestamp":1725357964000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2024.2767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,29]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2024.2767","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"article-number":"69"}}